skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Obesity, Fitness, & Wellness Week remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hoag Announces $25 Million Gift to Boldly Hoag Campaign
Hoag Announces $25 Million Gift to Boldly Hoag Campaign
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hoag Announces $25 Million Gift to Boldly Hoag Campaign

Obesity, fitness, & wellness week, 2024-04, p.1696

NewsRX LLC

Texto completo disponível

Citações Citado por
2
Endocrinology Research Centre Researchers Detail Findings in Antidiabetic Agents [Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog[R] Mix 25 (Lilly France, France) using the euglycemic ...]
Endocrinology Research Centre Researchers Detail Findings in Antidiabetic Agents [Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog[R] Mix 25 (Lilly France, France) using the euglycemic ...]
Material Type:
Artigo 		Adicionar ao Meu Espaço

Endocrinology Research Centre Researchers Detail Findings in Antidiabetic Agents [Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog[R] Mix 25 (Lilly France, France) using the euglycemic ...]

Obesity, fitness, & wellness week, 2019-11, p.714

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Universal Exome Sequencing in Critically Ill Adults: A Diagnostic Yield of 25% and Race-Based Disparities in Access to Genetic Testing (Updated April 1, 2024)
Universal Exome Sequencing in Critically Ill Adults: A Diagnostic Yield of 25% and Race-Based Disparities in Access to Genetic Testing (Updated April 1, 2024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Universal Exome Sequencing in Critically Ill Adults: A Diagnostic Yield of 25% and Race-Based Disparities in Access to Genetic Testing (Updated April 1, 2024)

Obesity, fitness, & wellness week, 2024-04, p.1187

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Cyteir Therapeutics, Inc. Files SEC Form 25, Notification of The Removal From Listing And Registration of Matured, Redeemed Or Retired Securities: (Mar. 18, 2024)
Cyteir Therapeutics, Inc. Files SEC Form 25, Notification of The Removal From Listing And Registration of Matured, Redeemed Or Retired Securities: (Mar. 18, 2024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cyteir Therapeutics, Inc. Files SEC Form 25, Notification of The Removal From Listing And Registration of Matured, Redeemed Or Retired Securities: (Mar. 18, 2024)

Obesity, fitness, & wellness week, 2024-04, p.1620

NewsRX LLC

Texto completo disponível

Citações Citado por
5
Magnetogenetic cell activation using endogenous ferritin (Updated April 25, 2024)
Magnetogenetic cell activation using endogenous ferritin (Updated April 25, 2024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Magnetogenetic cell activation using endogenous ferritin (Updated April 25, 2024)

Obesity, fitness, & wellness week, 2024-05, p.55

NewsRX LLC

Texto completo disponível

Citações Citado por
6
Applied Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Apr. 25, 2024)
Applied Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Apr. 25, 2024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Applied Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Apr. 25, 2024)

Obesity, fitness, & wellness week, 2024-05, p.1466

NewsRX LLC

Texto completo disponível

Citações Citado por
7
Bioxcel Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Mar. 25, 2024)
Bioxcel Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Mar. 25, 2024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bioxcel Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Mar. 25, 2024)

Obesity, fitness, & wellness week, 2024-04, p.1827

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Short repeat RNA reduces cytotoxicity by preventing the aggregation of TDP-43 and its 25 kDa carboxy-terminal fragment (Updated December 4, 2022)
Short repeat RNA reduces cytotoxicity by preventing the aggregation of TDP-43 and its 25 kDa carboxy-terminal fragment (Updated December 4, 2022)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Short repeat RNA reduces cytotoxicity by preventing the aggregation of TDP-43 and its 25 kDa carboxy-terminal fragment (Updated December 4, 2022)

Obesity, fitness, & wellness week, 2022-12, p.3759

NewsRX LLC

Texto completo disponível

Citações Citado por
9
Atomistic ensemble of active SHP2 phosphatase (Updated November 25, 2023)
Atomistic ensemble of active SHP2 phosphatase (Updated November 25, 2023)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atomistic ensemble of active SHP2 phosphatase (Updated November 25, 2023)

Obesity, fitness, & wellness week, 2023-12, p.549

NewsRX LLC

Texto completo disponível

Citações Citado por
10
Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling
Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stellaromics Secures $25 Million in Series A Funding to Advance 3D Spatial Multi-omic Profiling

Obesity, fitness, & wellness week, 2023-11, p.77

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Physical Fitness  (90.460)
  2. Obesity  (21.335)
  3. Cancer  (16.769)
  4. Medical Research  (15.228)
  5. Editors  (14.346)
  6. Medicine, Experimental  (14.333)
  7. Health Aspects  (11.904)
  8. Care And Treatment  (11.545)
  9. Analysis  (11.070)
  10. Oncology, Experimental  (10.388)
  11. Methods  (8.948)
  12. Intellectual Property  (7.861)
  13. Health  (7.441)
  14. Cancer Research  (7.397)
  15. Genetic Aspects  (6.061)
  16. Genetic Research  (4.532)
  17. Drug Therapy  (3.854)
  18. Risk Factors  (3.322)
  19. Patient Outcomes  (3.224)
  20. Physiological Aspects  (3.030)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (236)
  2. 2003Até2008  (5.605)
  3. 2009Até2012  (3.934)
  4. 2013Até2017  (27.028)
  5. Após 2017  (75.929)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.